Measured Wealth Private Client Group LLC Takes Position in CVS Health Co. (NYSE:CVS)

Measured Wealth Private Client Group LLC purchased a new position in shares of CVS Health Co. (NYSE:CVS) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,158 shares of the pharmacy operator’s stock, valued at approximately $252,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Dixon Mitchell Investment Counsel Inc. grew its position in CVS Health by 1.7% in the first quarter. Dixon Mitchell Investment Counsel Inc. now owns 694,255 shares of the pharmacy operator’s stock valued at $55,374,000 after acquiring an additional 11,402 shares in the last quarter. Cullinan Associates Inc. increased its stake in CVS Health by 10.6% during the 1st quarter. Cullinan Associates Inc. now owns 119,497 shares of the pharmacy operator’s stock worth $9,531,000 after buying an additional 11,444 shares during the period. FARMERS & MERCHANTS TRUST Co OF LONG BEACH lifted its holdings in CVS Health by 7.1% in the 1st quarter. FARMERS & MERCHANTS TRUST Co OF LONG BEACH now owns 3,002 shares of the pharmacy operator’s stock worth $239,000 after buying an additional 200 shares in the last quarter. Oak Thistle LLC purchased a new position in CVS Health in the 1st quarter valued at about $203,000. Finally, Claro Advisors LLC grew its stake in shares of CVS Health by 12.2% during the first quarter. Claro Advisors LLC now owns 9,172 shares of the pharmacy operator’s stock valued at $732,000 after acquiring an additional 1,000 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently commented on the company. Argus reduced their price target on CVS Health from $100.00 to $80.00 and set a “buy” rating for the company in a report on Wednesday, May 8th. The Goldman Sachs Group lowered their price target on CVS Health from $85.00 to $74.00 and set a “buy” rating for the company in a report on Thursday, May 2nd. Wells Fargo & Company reduced their price objective on CVS Health from $76.00 to $60.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 7th. SVB Leerink reissued a “market perform” rating and set a $60.00 target price (down from $87.00) on shares of CVS Health in a report on Wednesday, May 1st. Finally, JPMorgan Chase & Co. dropped their target price on CVS Health from $101.00 to $86.00 and set an “overweight” rating on the stock in a research report on Thursday, May 30th. Eleven research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat, CVS Health currently has an average rating of “Moderate Buy” and an average target price of $75.05.

Insider Activity at CVS Health

In other news, Director Edward J. Ludwig acquired 1,000 shares of CVS Health stock in a transaction dated Thursday, May 2nd. The stock was acquired at an average cost of $53.88 per share, for a total transaction of $53,880.00. Following the completion of the purchase, the director now owns 21,630 shares of the company’s stock, valued at $1,165,424.40. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.24% of the stock is owned by company insiders.

CVS Health Stock Down 1.1 %

CVS stock opened at $57.52 on Wednesday. The company has a 50 day moving average of $59.34 and a two-hundred day moving average of $70.02. The company has a quick ratio of 0.61, a current ratio of 0.81 and a debt-to-equity ratio of 0.78. CVS Health Co. has a 12-month low of $52.77 and a 12-month high of $83.25. The company has a market cap of $72.21 billion, a price-to-earnings ratio of 10.11, a PEG ratio of 0.56 and a beta of 0.52.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 EPS for the quarter, missing the consensus estimate of $1.69 by ($0.38). The business had revenue of $88.44 billion during the quarter, compared to the consensus estimate of $89.33 billion. CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The business’s revenue was up 3.7% on a year-over-year basis. During the same period in the prior year, the firm earned $2.20 earnings per share. On average, equities analysts anticipate that CVS Health Co. will post 7.02 earnings per share for the current fiscal year.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.